It could be observed from Figure 4a that G4/MTX-siRNA nanocomplex and G4-siRNA polyplex treatment groups significantly (p < 0.001) decreased the HMGA2 mRNA expression level in FR expressing cancer cells compared to the G4MTX nanosystem. This evidence concerns the gene HMGA2 and cancer.